Starpharma Holdings Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2024🗂️ Report periods on file: 2024, 2023

In its 2024 reporting, Starpharma Holdings Limited disclosed greenhouse gas emissions of 15.04 tCO2e/year (Scope 1 and 2). By scope: Scope 1: 15.04 tCO2e/year (approx.). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
15.04 tCO2e/year (Scope 1 and 2)
2024
💧
Water Usage
259 kl/year (estimated)
2024
♻️
Waste
42.2K kg/year (general waste) 57400 kg/year (recyclables)
2024

📊 Emissions by Scope (2024)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).15.04 tCO2e/year (approx.)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202415.04 tCO2e/year (Scope 1 and 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

EnvironmentOur PeopleProducts and Patient HealthGovernance

⚠️ Challenges & Risks +

  • Relatively low annual water usage makes setting a target to lower consumption currently infeasible.
  • Managing potential material risks and opportunities arising from a changing global climate and environmental landscape.

📋 Report Information

Reporting Period: 2024
Frameworks: UN Sustainable Development Goals, Ten Principles of the UN Global Compact, SASB Biotechnology and Pharmaceuticals Industry Standard